SCYNEXIS, Inc. Executive Officer Compensation Approval (2016 Bonuses, 2017 Salaries, and Stock Options)
Contract Categories:
Human Resources
›
Bonus & Incentive Agreements
Summary
SCYNEXIS, Inc.'s Board of Directors approved compensation for its executive officers, including Marco Taglietti (CEO), David Angulo (CMO), and Eric Francois (CFO). The agreement covers cash bonuses for 2016, new salaries effective March 1, 2017, and stock option grants under the company's 2014 Equity Incentive Plan. The stock options vest monthly over four years, provided the officers remain with the company. This document outlines the amounts and terms for each officer's compensation.
EX-10.34 3 exhibit1034.htm EXHIBIT 10.34 Exhibit
Exhibit 10.34
On January 31, 2017, the Board of Directors of SCYNEXIS, Inc. took the following compensation actions with respect to SCYNEXIS’s following executive officers (collectively, the “Officers”):
2016 Officer Bonuses
Approved cash bonuses for the Officers based on SCYNEXIS’s performance for the calendar year 2016:
Executive Officer | Title | Bonus | ||
Marco Taglietti, M.D. | Chief Executive Officer | $210,100 | ||
David Angulo, M.D. | Chief Medical Officer | $136,600 | ||
Eric Francois | Chief Financial Officer | $113,000 |
2017 Salaries
Approved the 2017 salaries for the Officers, to be effective March 1, 2017, as follows:
Executive Officer | Title | 2017 Salary | ||
Marco Taglietti, M.D. | Chief Executive Officer | $510,000 | ||
David Angulo, M.D. | Chief Medical Officer | $413,800 | ||
Eric Francois | Chief Financial Officer | $360,500 |
Option Grants
Approved stock option grants under SCYNEXIS 's 2014 Equity Incentive Plan to the following Officers:
Executive Officer | Title | Shares subject to Option | ||
Marco Taglietti, M.D. | Chief Executive Officer | 360,000 | ||
David Angulo, M.D. | Chief Medical Officer | 140,000 | ||
Eric Francois | Chief Financial Officer | 100,000 |
The options have an exercise price of $3.02 per share and vest on a monthly basis over a four-year period, provided such officer is continuing to provide services to SCYNEXIS on such vesting date.